follow @ClinPsychNews
RSS Feeds
Find Us on Facebook

Pain and Addiction

Stratify Patients for Opioid Misuse and Abuse Risk

By: ALICIA AULT, Clinical Psychiatry News Digital Network

NEW ORLEANS – Do you know which of your patients is likely to misuse or abuse opioid medications?

They can be stratified according to risk, but many physicians don’t know how or don’t take the time to do so, according to Dr. Lynn R. Webster, medical director of Lifetree Clinical Research in Salt Lake City and director at large for the American Academy of Pain Medicine.

It is important to try to prevent misuse or abuse, given that overdoses and deaths from prescription drugs are on the rise, said Dr. Webster at the American Medical Association House of Delegates Interim meeting.

According to the National Institute on Drug Abuse, emergency department visits involving nonmedical use of pharmaceuticals (either alone or in combination with another drug) increased 98% between 2004 and 2009, from 627,291 visits to 1.2 million visits. There was an 83% rise in emergency department visits involving adverse reactions to pharmaceuticals between 2005 and 2009, from 1.3 million to 2.3 million visits.

Opioids were the most frequently cited in those ED visits, accounting for about 50% of nonmedical use. Psychotherapeutic agents accounted for a third of the nonmedical use. According to the National Institute on Drug Abuse, the three most frequently cited drugs in those visits were hydrocodone (alone or in combination), accounting for 104,490 visits; oxycodone (alone or in combination), for 175,949 visits; and methadone, for 70,637 visits.

To properly assess and treat patients, physicians should understand and agree upon terminology, said Dr. Webster. Patients may "misuse" prescriptions if they are not taking them as directed. They aren’t seeking a high, they may just have undertreated pain, he said.

Abuse is the willful self-administration of a drug to get high. Addiction is a medical condition with complex genetic, psychosocial, and environmental factors that influence its development and manifestations. Addicts may have impaired control over drug use, compulsive use, or continued use despite harm.

"You don’t just put someone on an opioid and think you’ve done your job."

Pseudoaddiction results from undertreatment of pain, and may resolve with proper therapy. Patients in this state may manifest behavior that is misidentified as drug-seeking, according to Dr. Webster.

Even with chronic pain, "people prescribed opioids over a long period of time are going to have aberrant behavior," said Dr. Webster, noting that "it’s not a small problem." In research he conducted, up to 40% of patients in his chronic pain practice had aberrant behavior within a year of starting treatment.

But, he said, "only a small percent have the disease of addiction."

To prevent misuse and abuse, it’s important to understand patients’ motives, he said. Nonmedical users may have been prescribed pain medications, but they move on to recreational use and then, often, abuse.

Medical users generally are pain patients who are seeking more pain relief and end up misusing the drugs. They also may become abusers. In all, 40%-60% have other chronic conditions for which opioids provide relief, such as anxiety, said Dr. Webster. That use is obviously not appropriate, but it can only be prevented if physicians fully assess pain patients.

There is a constellation of risk factors that help determine potential for misuse and abuse, according to Dr. Webster.

12/05/11  

FROM THE AMERICAN MEDICAL ASSOCIATION HOUSE OF DELEGATES INTERIM MEETING

Bookmark and Share


Submitting your vote...
Not rated yet. Be the first who rates this item!
Click the rating bar to rate this item.

I would like to receive Clinical Psychiatry News E-Newsletter The Cognoscenti each week.


Specialty Focus
Sponsored by


calendar
May 24 - 27
Chicago, IL
Association for Psychological Science (APS): Annual Convention
May 29 - Jun 1
Phoenix, AZ
National Institute of Mental Health (NIMH): New Clinical Drug Evaluation Unit (NCDEU)
Jun 3 - 7
Stockholm,
Collegium Internationale Neuro-Psychopharmacologicum (CINP): World Congress
Jun 5 - 10
Kona, HI
International Behavioral Neuroscience Society (IBNS): Annual Meeting
Jun 12 - 17
Chicago, IL
American Psychoanalytic Association (APsaA): 101st Annual Meeting
Jun 18 - 26
Rapid City, SD
Reclaiming Youth International: 19th Annual Black Hills Seminars
Jun 23 - 27
San Francisco, CA
Research Society on Alcoholism (RSA): Annual Scientific Conference
Jul 10 - 13
Liverpool,
Royal College of Psychiatrists: Annual Meeting
Jul 21 - 28
Dpart Venice,
Primary Care: Mental Health Issues with a Focus on Drugs and Behavior
Jul 21 - 25
Paris,
International Association for Child & Adolescent Psych & Allied Professions (IACAPAP): World Congress
More Calendar »